Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy

[1]  L. Terracciano,et al.  Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. , 2013, Human pathology.

[2]  J. Tjandra,et al.  Practice parameters for the management of rectal cancer (revised). , 2013, Diseases of the colon and rectum.

[3]  E. Patsouris,et al.  Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer , 2013, Modern Pathology.

[4]  R. Riddell,et al.  Tumor budding in colorectal carcinoma: time to take notice , 2012, Modern Pathology.

[5]  Takatoshi Nakamura,et al.  Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy , 2012, Histopathology.

[6]  J. Gu,et al.  Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy. , 2012, Human pathology.

[7]  M. Kurrer,et al.  Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer , 2012, Modern Pathology.

[8]  T. Smyrk,et al.  Partial Pathologic Response and Nodal Status as Most Significant Prognostic Factors for Advanced Rectal Cancer Treated With Preoperative Chemoradiotherapy , 2012, World Journal of Surgery.

[9]  Lawrence J. Burgart,et al.  Meta-analysis of Histopathological Features of Primary Colorectal Cancers that Predict Lymph Node Metastases , 2012, Journal of Gastrointestinal Surgery.

[10]  L. Terracciano,et al.  Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. , 2011, Human pathology.

[11]  J. O’Sullivan,et al.  Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status , 2011, International Journal of Surgical Pathology.

[12]  Giacomo Puppa,et al.  TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. , 2010, Archives of pathology & laboratory medicine.

[13]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[14]  K. Togashi,et al.  Evaluation of Venous Invasion by Elastica van Gieson Stain and Tumor Budding Predicts Local and Distant Metastases in Patients With T1 Stage Colorectal Cancer , 2009, The American journal of surgical pathology.

[15]  J. Sánchez,et al.  Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy , 2009, International Journal of Colorectal Disease.

[16]  J. O’Sullivan,et al.  Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer , 2009, The American journal of surgical pathology.

[17]  K. Sheahan,et al.  A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy , 2008, Annals of Surgical Oncology.

[18]  M. Gonen,et al.  Pathologic stage is most prognostic of disease‐free survival in locally advanced rectal cancer patients after preoperative chemoradiation , 2008, Cancer.

[19]  I. Nagtegaal,et al.  Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Skibber,et al.  Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer , 2007, Cancer.

[21]  H. Mitomi,et al.  Tumour budding at invasive margins and outcome in colorectal cancer , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[22]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[23]  F. Prall.  Tumour budding in colorectal carcinoma , 2007, Histopathology.

[24]  Y. Park,et al.  Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer , 2006, Journal of surgical oncology.

[25]  H. Nagawa,et al.  Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2 , 2006, British Journal of Cancer.

[26]  H. Mitomi,et al.  Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. , 2005, Hepato-gastroenterology.

[27]  D. Treanor,et al.  Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer , 2005, Histopathology.

[28]  M. Barten,et al.  Tumour budding as prognostic factor in stage I/II colorectal carcinoma , 2005, Histopathology.

[29]  K. Guzińska-ustyMowiCz.  The role of tumour budding at the front of invasion and recurrence of rectal carcinoma. , 2005, Anticancer research.

[30]  H. Ueno,et al.  Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer , 2002, Histopathology.

[31]  U. Mansmann,et al.  The prognostic inhomogeneity of colorectal carcinomas Stage III , 2001, Cancer.

[32]  M. Morimatsu,et al.  An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer , 1989, Cancer.

[33]  T. Morodomi.  [Clinicopathological studies of advanced rectal cancers--prediction of the degree of lymph node metastasis from histopathological finding of pre-operative biopsy specimens]. , 1988, Nihon Geka Gakkai zasshi.